| 1.69 Data as of May 17 |  +0.01 / +0.60%Today’s Change | 1.18 Today|||52-Week Range 3.96 | -33.98% Year-to-Date |
| Previous close | 1.68 |
| Today’s open | 1.70 |
| Day’s range | 1.67 - 1.72 |
| Volume | 50,060 |
| Average volume (3 months) | 115,674 |
| Market cap | $16.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +75.85% |
| Earnings growth (this year) | +40.49% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -71.69% |
| P/E ratio | 0.3 |
| Price/Sales | 205.90 |
| Price/Book | 1.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPXAOpexa Therapeutics I... | -0.07 | -4.02% |
| --Islet Sciences Inc | 0.00 | 0.00% |
| FSIFlexible Solutions I... | -0.08 | -8.57% |
| BASIBioanalytical System... | +0.00 | +0.15% |
| Next reporting date | May 20, 2013 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $62.1K |
| Annual profit (last year) | -$9.2M |
| Net profit margin | -14,827.80% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Stephen T. Lundy |
Chief Financial Officer & Secretary Jeffrey G. McGonegal, CPA |
Corporate headquarters Castle Rock, Colorado |
.
